Scholarlink

Fluoroquinolone-associated disability (FQAD), as a severe, disabling, syndrome-like condition, is now a scientifically substantiated and recognized disease entity. This chapter summarizes the numerous evidence-based facts regarding pathogenesis and diagnostics and provides an outlook on possible treatment options.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

FQAD: Pathogenesis, Diagnosis, and Therapy

  • 章节

  • 发表日期：

    2025年

查看全文
  • Stefan Pieper

摘要

Fluoroquinolone-associated disability (FQAD), as a severe, disabling, syndrome-like condition, is now a scientifically substantiated and recognized disease entity. This chapter summarizes the numerous evidence-based facts regarding pathogenesis and diagnostics and provides an outlook on possible treatment options.